Companion Diagnostics

News on companion diagnostics and drug/test co-development.

Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China

The firms will codevelop companion diagnostics for anti-PD1/PD-L1 immunotherapy treatments for cancer.

Merck, Promega Collaborate to Develop MSI CDx for Keytruda

Promega's microsatellite instability technology will be used to develop an on-label, solid tumor companion diagnostic for pembrolizumab.

Qiagen Expands Immuno-Oncology Portfolio With Three Agreements

The company has signed technology deals with Repertoire Genesis of Japan, Stratifyer Molecular Pathology of Germany, and the University of Bonn.

Qiagen Interim CEO Explains Reduced FY19 Revenue Guidance, Provides Vision for Growth

Premium

Newly appointed interim CEO Thierry Bernard attempted to assuage investors' fears in the wake of a tumultuous month for Qiagen.

Qiagen Q3 Revenues Grow 1 Percent as Firm Lowers Full-Year Guidance

The lowered guidance is due to continued expected weakness in China, exacerbated by the company's decision to halt the development of new next-generation sequencing instruments.

Oct 29, 2019

FDA Approval of Myriad Genetics CDx Adds HRD to Growing List of Ovarian Cancer Predictive Markers

Premium

Oct 29, 2019

NeoGenomics Q3 Revenues Grow 51 Percent

Oct 23, 2019

FDA Approves GSK's Zejula Alongside Myriad Genetics CDx for Advanced Ovarian Cancer

Oct 22, 2019

Report Says Many Precision Drugs Will Launch in Coming Years But Unclear if They Will Reach Patients

Premium

Oct 08, 2019

Qiagen Nixes Sequencer Development, Sees New NGS Opportunities With Illumina Deal

Premium

Oct 08, 2019

Novogene, Chipscreen Ink CDx Development Deal

Oct 04, 2019

Prometheus Biosciences, Takeda Pharmaceutical to Codevelop Targeted Therapies, CDx for IBD

Sep 09, 2019

Thermo Fisher Scientific, Eli Lilly to Develop CDx for RET Inhibitor

Sep 09, 2019

Biolidics, Hangzhou Normal University Form Cancer Biomarker Alliance

Aug 16, 2019

Foundation Medicine to Seek FDA Approval for FoundationOne as CDx to Genentech's Rozlytrek

Aug 07, 2019

Myriad Genetics Seeking Additional FDA Approval for BRACAnalysis CDx

Jul 30, 2019

NeoGenomics Q2 Revenues Jump 50 Percent

Jul 23, 2019

China's NMPA Extends Approval for Roche Cobas EGFR Mutation Test v2 to Plasma Samples

Jul 08, 2019

Ayala, ArcherDX Partner to Advance CDx for Notch Inhibitors

Jul 01, 2019

FDA Approves Foundation Medicine CDx Test for Lynparza

Jun 27, 2019

Japanese Regulator Approves Foundation Medicine CDx Assay for Roche's Rozlytrek

Jun 19, 2019

Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug

Jun 19, 2019

Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer

Jun 19, 2019

AstraZeneca, Merck's Lynparza, Myriad Genetics' BRCA Test Approved in Japan

Jun 05, 2019

Almac NGS-Based CDx Gets CE Mark

The Scan

Google's Health Info Gathering

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

Against the Plan

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

'Bias Throughout the Pipeline'

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

PNAS Papers Explore tRNA Fragment Signature in CLL, UV Hypermutated Melanocyte Sites, More

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.

Featured White Papers

Evaluation of the Oncomine BRCA Research Assay for Variant Detection by Next-Generation Sequencing

Nov

19

Featured Webinar

Digital PCR for Tag Copy Number Assessment in CRISPR-Edited Cell Lines

Fluorescent proteins or self-labeling tags are invaluable tools for studying protein dynamics in living cells using fluorescence microscopy. However, quantitative imaging requires physiological levels of expression of the target protein of interest (POI), especially when stoichiometric interactions of the POI need to be investigated.

Dec

05

Featured Webinar

Improving the Diagnosis of Infectious Diseases with Microbial Genomic Analysis

The discovery of microbial cell-free DNA has propelled the introduction of new technologies that can be leveraged for next-generation diagnostic assays. Previously inaccessible genomic information can now be comprehensively surveyed for microorganisms, all from a single blood draw.

Menu

Companion Diagnostics

What's Popular?

Sponsorships